Comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125
Diabetes Care
.
2013 Dec;36(12):e213.
doi: 10.2337/dc13-1134.
Authors
Lotte Bjerre Knudsen
1
,
Niels C Berg Nyborg
,
Claus Bo Svendsen
,
Niels Vrang
,
Alan C Moses
Affiliation
1
Corresponding author: Lotte Bjerre Knudsen, lbkn@novonordisk.com.
PMID:
24265382
PMCID:
PMC3836151
DOI:
10.2337/dc13-1134
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Humans
Incretins / therapeutic use*
Substances
Incretins